Familial Hypercholesterolemia (FH)

Overview

Familial hypercholesterolemia is a genetic condition in which LDL cholesterol — commonly known as "bad cholesterol" — is elevated from birth and remains persistently high throughout life. In a healthy person, liver cells remove LDL cholesterol from the bloodstream using specialized proteins called LDL receptors. In familial hypercholesterolemia, these receptors either do not work at all or function poorly, so LDL cholesterol accumulates in the blood and reaches dangerous levels that diet and exercise alone cannot adequately address.

The condition is caused by a mutation in a single gene inherited from one or both parents. When only one copy of the affected gene is inherited — the more common scenario — the result is heterozygous familial hypercholesterolemia, which affects approximately 1 in 250 to 500 people. When mutated genes are inherited from both parents, the result is homozygous familial hypercholesterolemia — far rarer but significantly more severe.

Familial hypercholesterolemia is fundamentally different from the high cholesterol that results from an unhealthy lifestyle. It develops independently of diet and exercise, cannot be fully corrected through dietary changes alone, and — when left untreated — leads to premature and accelerated cardiovascular disease. Because it produces no symptoms in the vast majority of people, many individuals are diagnosed late or not at all. Early diagnosis and appropriate medical treatment can dramatically reduce this risk.

Symptoms

The most insidious feature of familial hypercholesterolemia is that it causes no symptoms for many years. Cholesterol builds up silently in artery walls, and many people first become aware of the condition only after suffering a heart attack or stroke. Some physical signs may, however, be detected on careful examination.

Familial hypercholesterolemia signs and symptoms include the following:

• Tendon xanthomas. These are firm, yellowish nodules caused by cholesterol deposits in tendons. They occur most commonly in the Achilles tendons and the tendons over the finger joints. They feel hard to the touch, grow gradually over years, and are the most characteristic physical finding of familial hypercholesterolemia.
• Xanthelasmas. These are soft, slightly raised yellowish deposits that form at the inner corners of the eyelids. They are cosmetically noticeable but painless. Xanthelasmas are not specific to familial hypercholesterolemia and can also appear in people with normal cholesterol levels.
• Corneal arcus. This is a white or grey ring that forms around the colored part of the eye (the iris). When it appears in someone under the age of 45, it is a meaningful warning sign and should prompt cholesterol evaluation.
• Premature cardiovascular disease. Untreated familial hypercholesterolemia causes rapid atherosclerosis in the coronary arteries. This can manifest as a heart attack or angina (chest pain) in someone in their 30s or 40s — or even younger. A family history of early-onset heart disease is therefore an important diagnostic clue.
• Much earlier and more severe presentation in the homozygous form. Individuals who have inherited the mutation from both parents have extremely high LDL levels and may develop tendon xanthomas and cardiovascular events even in childhood.

Because most of these physical signs are painless and easy to overlook, familial hypercholesterolemia is frequently identified only through routine blood tests showing unexpectedly high cholesterol, or when a family history of premature heart disease prompts further investigation.

When to See a Doctor

Since familial hypercholesterolemia rarely causes symptoms, early screening of people at risk is strongly recommended rather than waiting for problems to appear.

Schedule a medical evaluation if:

• A male relative suffered a heart attack before age 55, or a female relative before age 65
• A parent or sibling has been diagnosed with high cholesterol or familial hypercholesterolemia
• Your children have not been screened and there are risk factors in the family
• You have noticed swelling or firmness along your tendons, especially around the heels or fingers
• You have yellowish deposits on your eyelids or a white or grey ring around your iris
• A previous blood test showed high total or LDL cholesterol and the cause was never investigated

When one person in a family is diagnosed with familial hypercholesterolemia, it is important that all first-degree relatives — parents, siblings, and children — are also screened. This approach, known as cascade screening, has become standard practice in many countries and is one of the most effective ways to identify new cases early.

Causes

Familial hypercholesterolemia is caused by a mutation in a gene involved in the LDL receptor pathway — the system by which the liver identifies and clears LDL cholesterol from the bloodstream. When this pathway is disrupted, LDL cholesterol accumulates rather than being removed.

The genetic changes responsible for familial hypercholesterolemia include the following:

• LDLR gene mutations. The vast majority of cases are caused by mutations in the gene that encodes the LDL receptor protein directly. These mutations can prevent the receptor from being produced, cause it to fold incorrectly, or stop it from reaching the surface of liver cells. More than 2,000 distinct mutations in this gene have been identified to date.
• APOB gene mutations. The ApoB protein sits on the surface of LDL particles and acts as the docking molecule that binds to LDL receptors. Mutations in the APOB gene prevent LDL particles from binding to their receptors properly, so they cannot be taken up and cleared from the blood.
• PCSK9 gain-of-function mutations. The PCSK9 protein normally acts as a regulator that degrades LDL receptors after they have done their job. Certain gain-of-function mutations make PCSK9 overactive, resulting in fewer LDL receptors on liver cells and a reduced capacity to clear LDL from the blood.
• Pattern of inheritance. The condition is inherited in an autosomal dominant pattern, meaning that just one affected copy of the relevant gene is sufficient to cause the disease. If one parent has familial hypercholesterolemia, each child has a 50 percent chance of inheriting the condition. When both parents carry a mutation, the child may inherit mutations from both, leading to the far more severe homozygous form.

Risk Factors

Because familial hypercholesterolemia is a genetic condition, the primary risk factor is family history. Lifestyle and diet do not determine whether someone has the condition, though they can influence its severity and the overall level of cardiovascular risk.

• Family history of familial hypercholesterolemia. Having a parent diagnosed with the condition raises each child's likelihood of carrying it to approximately 50 percent. Screening all first-degree relatives of a diagnosed individual is therefore strongly recommended.
• Family history of early cardiovascular disease. Male relatives who had a heart attack before age 55, or female relatives before age 65, are a strong signal that familial hypercholesterolemia may be present in the family.
• Very high LDL cholesterol. An LDL level above 190 mg/dL — particularly in a young person and especially when it cannot be explained by diet or lifestyle — should prompt consideration of familial hypercholesterolemia.
• Ethnicity. Familial hypercholesterolemia is more prevalent in certain populations due to founder effects, including Ashkenazi Jews, French Canadians, Lebanese, and South African Afrikaners.
• Coexisting cardiovascular risk factors. Smoking, diabetes, obesity, and hypertension compound the already elevated cardiovascular risk in people with familial hypercholesterolemia. While the genetic risk cannot be altered, controlling these additional factors is critically important.

Diagnosis

Familial hypercholesterolemia is diagnosed by combining blood test results, physical findings, personal and family history, and — when appropriate — genetic testing. The most widely used diagnostic framework is the Dutch Lipid Clinic Network (DLCN) criteria, which assigns points to each of these elements and classifies the likelihood of diagnosis as definite, probable, possible, or unlikely.

Diagnostic methods include the following:

• Fasting lipid panel. Total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides are measured from a fasting blood sample. In familial hypercholesterolemia, LDL cholesterol is typically above 190 mg/dL and often well above 250–300 mg/dL. In the homozygous form, LDL may exceed 500 mg/dL. LDL levels that are far higher than can be explained by diet or physical inactivity should always prompt further investigation.
• Physical examination. The clinician looks for tendon xanthomas, xanthelasmas, and corneal arcus. These findings strongly support the diagnosis, though their absence does not rule it out.
• Detailed family history. Information about elevated cholesterol, premature heart attacks, strokes, and sudden cardiac death among first- and second-degree relatives is essential for assigning diagnostic probability.
• Genetic testing. Identifying a mutation in the LDLR, APOB, or PCSK9 gene provides a definitive diagnosis. Genetic testing is not required in every case, but it is valuable when the diagnosis is uncertain, when cascade screening of family members is being organized, or when a confirmed genetic result would influence treatment decisions. A positive result also allows relatives to be tested with a simple, targeted test rather than a full lipid workup.
• Cardiovascular assessment. Once the diagnosis is established, the extent of existing atherosclerosis is evaluated using ECG, stress testing, echocardiography, or coronary CT angiography as appropriate. These tests help quantify current cardiovascular risk and guide treatment intensity.

Treatment

Because familial hypercholesterolemia is a genetic condition, lifestyle changes alone are insufficient — medication is essential. The goal of treatment is to lower LDL cholesterol to a level that prevents or significantly delays cardiovascular damage, and to maintain that level for life.

Treatment options include the following:

• Statins. These are the cornerstone of treatment. By blocking a key enzyme in the liver's cholesterol synthesis pathway, statins reduce LDL cholesterol by 40–60 percent. Rosuvastatin and atorvastatin are the most potent and widely used agents. In familial hypercholesterolemia, the highest tolerated statin dose is recommended, and treatment should be started as early as possible. Muscle aches and mildly elevated liver enzymes are the most commonly reported side effects, but most patients tolerate statins well.
• Ezetimibe. This drug reduces the absorption of cholesterol from the gut. While modestly effective on its own, it lowers LDL by an additional 15–25 percent when added to statin therapy. It is a particularly useful option for patients who cannot tolerate full-dose statins due to side effects.
• PCSK9 inhibitors. These injectable biologic medications block the PCSK9 protein, preventing it from degrading LDL receptors. The result is more receptors on liver cells and a reduction in LDL cholesterol of 50–60 percent. Evolocumab and alirocumab are administered as subcutaneous injections every two weeks or monthly. They are used in patients who cannot reach LDL targets despite maximally tolerated statin and ezetimibe therapy, or in those who cannot take statins due to severe muscle side effects.
• Inclisiran. A newer medication that silences PCSK9 production at the RNA level, inclisiran requires only two injections per year, making it a convenient option for long-term maintenance therapy.
• Bile acid sequestrants. These agents bind bile acids in the gut and prevent their reabsorption, forcing the liver to use more cholesterol to produce new bile acids. They are an alternative when statins cannot be used and are considered safe during pregnancy.
• LDL apheresis. In patients with homozygous familial hypercholesterolemia or in those who do not respond adequately to medication, LDL apheresis is used to mechanically remove LDL cholesterol from the blood — a process that works somewhat like dialysis. It is typically performed weekly or every two weeks.
• Lifestyle modifications. While insufficient on their own, dietary and lifestyle changes enhance the effectiveness of drug treatment. Limiting saturated fat and trans fat, increasing fiber and omega-3 fatty acid intake, exercising regularly, quitting smoking, and maintaining a healthy weight all contribute meaningfully to reducing overall cardiovascular risk.
• Treatment in children. For children diagnosed with familial hypercholesterolemia, statin therapy is generally recommended from around ages 8–10. Early intervention slows or prevents the accumulation of arterial plaque that would otherwise begin in childhood and adolescence.

Complications

The most serious consequence of untreated or inadequately treated familial hypercholesterolemia is premature cardiovascular disease. Decades of elevated LDL cholesterol accelerate atherosclerosis rapidly and silently.

• Early heart attack. Without treatment, approximately half of men with heterozygous familial hypercholesterolemia experience a heart attack by the age of 50; a significant proportion of women do so by age 60. In the homozygous form, this risk materializes much earlier.
• Coronary artery disease and angina. Rapid atherosclerosis in the coronary arteries leads to chest pain during exertion and reduced exercise capacity. Early bypass surgery or stent placement may be required.
• Stroke. Atherosclerosis in the carotid and cerebral arteries increases stroke risk substantially. People with familial hypercholesterolemia have a markedly higher stroke risk than the general population.
• Peripheral artery disease. Atherosclerosis affecting the leg arteries causes pain when walking, poor wound healing, and in advanced cases tissue loss.
• Aortic stenosis. Particularly in homozygous familial hypercholesterolemia, rapid calcification of the aortic valve and root can cause severe aortic stenosis at a young age.
• Psychological impact. Living with a hereditary condition — and knowing that children may have inherited it — can cause anxiety, guilt, and depression. Psychological support and genetic counseling play an important role in holistic care.

Living with Familial Hypercholesterolemia

Familial hypercholesterolemia is a lifelong condition, but with appropriate treatment and a thoughtful approach to lifestyle, the majority of people can protect their cardiovascular health and live full, active lives. The diagnosis should be viewed as both a call to action and an opportunity — one that, when acted on early, can change the trajectory of the condition profoundly.

Commit to Medication

The fact that you feel well is not a reason to stop taking cholesterol-lowering medication — it is actually a sign that the medication is working. Stopping or skipping doses allows LDL to rise again and allows silent arterial damage to resume. Take medications at the same time every day, and if side effects arise, discuss them with your doctor rather than stopping independently. Alternatives are almost always available.

Dietary Choices

Diet alone cannot correct familial hypercholesterolemia, but it can meaningfully support the effectiveness of medication. Limit saturated fat sources such as butter, fatty red meat, processed meats, and full-fat dairy. A diet rich in oats, legumes, vegetables, fruit, and oily fish provides fiber and omega-3 fatty acids that contribute to a modestly better lipid profile. Avoid foods containing trans fats entirely.

Regular Exercise

Aerobic exercise raises HDL cholesterol, lowers triglycerides, and strengthens the cardiovascular system. Aim for at least 150 minutes of moderate-intensity activity per week — walking, swimming, cycling, and dancing are all excellent choices. If a formal cardiovascular assessment has not yet been done, check with your doctor before significantly increasing your exercise intensity.

Stop Smoking

Smoking multiplies an already elevated cardiovascular risk in people with familial hypercholesterolemia. Quitting smoking is the single most impactful lifestyle change a person with this condition can make.

Alert Your Family

When you receive a diagnosis of familial hypercholesterolemia, informing your first-degree relatives is both a moral responsibility and a potentially life-saving act. Siblings, children, and parents should all be tested. Early diagnosis in children means treatment can begin before significant arterial damage has occurred.

Regular Monitoring

Lipid panels and liver function tests should be repeated at regular intervals to assess treatment response. Medication doses or combinations should be adjusted as needed to meet LDL targets. A cardiology review at least once a year is advisable, particularly for those with established cardiovascular disease or those who have not yet reached treatment goals.

Preparing for Your Appointment

Coming to your appointment well prepared makes the consultation more efficient and helps your doctor reach an accurate assessment more quickly.

What you can do:

• Bring any previous cholesterol test results and reports
• Document your family's cardiac history in detail, including the ages at which relatives had heart attacks, strokes, or bypass surgery
• List all current medications, vitamins, and supplements
• Describe any physical findings you have noticed, such as tendon swellings, eyelid deposits, or a ring around the iris
• If you have previously taken cholesterol-lowering medication and stopped, explain why
• Write down your questions in advance

Questions you may wish to ask your doctor:

• Do I have familial hypercholesterolemia, or could another cause explain my cholesterol levels?
• Should I have genetic testing?
• What LDL target should I be aiming for?
• Which medication do you recommend, and for how long will I need to take it?
• What side effects should I watch out for, and how will I be monitored?
• Should my children and siblings be screened?
• Do I need further tests to assess my heart and blood vessels?
• What dietary and lifestyle changes will make the most difference?

Questions your doctor may ask:

• Has anyone in your family had a heart attack or stroke at a young age?
• Has a parent or sibling been diagnosed with high cholesterol or familial hypercholesterolemia?
• Have you had your cholesterol tested before? What were the results?
• Have you noticed any swelling or firmness in your tendons?
• Have you noticed yellowish deposits on your eyelids or a ring around your iris?
• Do you smoke?
• Do you have diabetes, high blood pressure, or any other chronic condition?
• Have you ever taken cholesterol-lowering medication?